Cited by 778Open Access
Chugai Pharma (United States)
ORCID: 0000-0001-5998-4532Publishes on CRISPR and Genetic Engineering, RNA and protein synthesis mechanisms, Mitochondrial Function and Pathology. 28 papers and 1.8k citations.
Add your photo, update your bio, and get notified when your ranking changes.
We studied the serum lipoprotein and apolipoprotein profiles in 44 patients with sporadic late-onset Alzheimer's dementia and 43 patients with vascular dementia. The levels of high-density lipoprotein (HDL) cholesterol were lower in both patient groups than in a control group. Apolipoprotein A I and A II levels have decreased in both the patient groups, especially in the vascular dementia group. The HDL-cholesterol levels correlated positively with the level of apolipoprotein A I, but not with the level of apolipoprotein A II. The ratios of apolipoprotein A I/A II have increased in both the patient groups. The apolipoprotein A II levels have disproportionally decreased in the patient groups. The serum apolipoprotein A II may involve the pathological process in the patients with senile dementia.